RBC Capital Reinstates Outperform on Healthpeak Properties, Announces $21 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Michael Carroll reinstates Healthpeak Properties (NYSE:DOC) with an Outperform rating and sets a price target of $21.
March 08, 2024 | 12:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Healthpeak Properties reinstated with an Outperform rating and a $21 price target by RBC Capital.
The reinstatement of Healthpeak Properties by RBC Capital with an Outperform rating and a specific price target of $21 suggests a positive outlook on the company's stock. This analyst rating can influence investor sentiment and potentially lead to an increase in stock price in the short term, as it signals confidence in the company's future performance.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100